ClassID:

97341

C07K2319/42 - CPC Classification

Classification description:

Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag

Recent Application in this class:
#1
20250368706
2025-12-04

SYNAPSE SURGERY TOOLS AND ASSOCIATED METHODS FOR NEURAL CIRCUIT-SPECIFIC SYNAPSE ABLATION AND MODIFICATION

#2
20250333748
2025-10-30

A DEGRON FOR REGULATING PROTEIN EXPRESSION AND METHODS THEREOF

#3
20250304715
2025-10-02

COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS

#4
20250251391
2025-08-07

RIBOSOMAL ENGAGEMENT POTENCY ASSAY

#5
20250236671
2025-07-24

CD229 Car T Cells And Methods Of Use Thereof

#6
20250228955
2025-07-17

PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS

#7
20250161427
2025-05-22

IMMUNOREACTIVE PEPTIDES

#8
20250092143
2025-03-20

GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY

#9
20250092129
2025-03-20

COMPOSITIONS AND METHODS USEFUL IN PROMOTING MILK PRODUCTION

#10
20240424075
2024-12-26

Immunoreactive peptides

#11
20240352123
2024-10-24

HIGH SELECTIVE CD229 ANTIGEN BINDING DOMAINS AND METHODS OF USE

#12
20240350607
2024-10-24

TUBERCULOSIS VACCINES

#13
20240230667
2024-07-11

MULTIPLEXED IMMUNOHISTOCHEMISTRY USING RECOMBINANT ANTIBODIES WITH EPITOPE TAGS

#14
20240197917
2024-06-20

GENE THERAPY

#15
20240197877
2024-06-20

BINDING PROTEINS RECOGNIZING HA-2 ANTIGEN AND USES THEREOF

#16
20240165154
2024-05-23

METHODS AND AGENTS FOR MODULATING ADOPTIVE IMMUNOTHERAPY

#17
20240025953
2024-01-25

COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION

#18
20230416309
2023-12-28

FUSION PROTEIN AND APPLICATION THEREOF

#19
20230364139
2023-11-16

METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA

#20
20230285537
2023-09-14

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

#21
20230272040
2023-08-31

STEALTH CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF IN REDUCING CYTOTOXICITY TOWARDS NORMAL CELLS

#22
20230250135
2023-08-10

INFLUENZA VIRUS VACCINES AND USES THEREOF

#23
20230235092
2023-07-27

ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

#24
20230203532
2023-06-29

RECOMBINANT POLYPEPTIDES FOR PROGRAMMING EXTRACELLULAR VESICLES

#25
20230174618
2023-06-08

ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF

#26
20230160885
2023-05-25

Microbial nanowires modified to contain peptides and methods of making

#27
20230151092
2023-05-18

CD229 Car T Cells And Methods Of Use Thereof

#28
20230065226
2023-03-02

HOMODIMERIC PROTEIN CONSTRUCTS

#29
20230035235
2023-02-02

SWI/SNF FAMILY CHROMATIN REMODELING COMPLEXES AND USES THEREOF

#30
20220411535
2022-12-29

COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS

#31
20220315660
2022-10-06

Antibodies targeting B-cell maturation antigen and methods of use

#32
20220288235
2022-09-15

SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS ESSENTIAL FOR SOCIAL MEMORY

#33
20220267478
2022-08-25

PEPTIDE-LOADED CARRIER SYSTEMS AND USES THEREOF

#34
20220226502
2022-07-21

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF CYSTATHIONINE BETA-SYNTHASE (CBS) ENZYME FOR TREATING CBS DEFICIENCY

#35
20220057408
2022-02-24

Multiplexed immunohistochemistry using recombinant antibodies with epitope tags

#36
20220056072
2022-02-24

N- and C-terminal tandem tag system for purification

#37
20220033448
2022-02-03

METHODS FOR AGGREGATION OF PROTEINS

#38
20210324043
2021-10-21

ApoC-II mimetic peptides

#39
20210171601
2021-06-10

LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE

#40
20210121560
2021-04-29

Vaccines for human papilloma virus and methods for using the same

#41
20210079424
2021-03-18

AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in the treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others

#42
20200405640
2020-12-31

Synthetic extracellular vesicles for novel therapies

#43
20200354700
2020-11-12

CAS9-nucleic acid complexes and uses related thereto

#44
20200339676
2020-10-29

Compositions and methods useful in promoting milk production

#45
20200239568
2020-07-30

Homodimeric protein constructs

#46
20200224185
2020-07-16

A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES

#47
20200172576
2020-06-04

FUSION POLYPEPTIDE AND METHOD FOR PRODUCING FUSION POLYPEPTIDE

#48
20200140522
2020-05-07

ApoC-II mimetic peptides

#49
20200123266
2020-04-23

Antibodies targeting b-cell maturation antigen and methods of use

#50
20190343965
2019-11-14

Phage conjugates and uses thereof

#51
20190330338
2019-10-31

CD229 CAR T cells and methods of use thereof

#52
20190330310
2019-10-31

Membrane span-kinase fusion protein and the uses thereof

#53
20190309324
2019-10-10

AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others

#54
20190307870
2019-10-10

Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections

#55
20190224305
2019-07-25

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

#56
20190192650
2019-06-27

Vaccines for human papilloma virus and methods for using the same

#57
20190185531
2019-06-20

Selective Bfl-1 peptides

#58
20190136216
2019-05-09

Botulinum neurotoxin and its derivatives

#59
20190127490
2019-05-02

Methods of making gels and films using curli nanofibers

#60
20190119343
2019-04-25

Artificial synapse inducer and method of making the same

#61
20190094242
2019-03-28

Multiplexed immunohistochemistry using recombinant antibodies with epitope tags

#62
20190055318
2019-02-21

Eliminating MHC restriction from the T cell receptor as a strategy for immunotherapy

#63
20190048391
2019-02-14

COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS

#64
20190018005
2019-01-17

Tandemly repeated antibody-binding protein and its applications

#65
20180346531
2018-12-06

COMPOSITIONS AND METHODS FOR DELIVERING BIOTHERAPEUTICS

#66
20180344842
2018-12-06

INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM

#67
20180312546
2018-11-01

Tagged hepadnavirus E antigen and its use in screening antiviral substances

#68
20180250383
2018-09-06

Methods of treating and preventing influenza infections

#69
20180208943
2018-07-26

Adeno-associated viruses engineered for selectable tropism

#70
20180162926
2018-06-14

Libraries of modified fibronectin type III tenth domain-containing polypeptides

#71
20180149638
2018-05-31

Method for screening pharmaceuticals for treatment of steatohepatitis using N-terminal dimerization of apoptosis signal-regulated kinase1

#72
20170342113
2017-11-30

RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF

#73
20170335361
2017-11-23

Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant body

#74
20170240627
2017-08-24

Single-chain variable fragment anti-CD133 antibodies and uses thereof

#75
20170240600
2017-08-24

Tagged hepadnavirus e antigen and its use in screening antiviral substances

#76
20170183392
2017-06-29

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

#77
20170182149
2017-06-29

Composite antigenic sequences and vaccines

#78
20170166950
2017-06-15

COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS

#79
20170096493
2017-04-06

Anti human Notch4 antibody

#80
20170080080
2017-03-23

Combinatorial platform for the display of surface adjuvants and antigens

#81
20170044235
2017-02-16

Biomolecule-releasing cell and selection thereof by means of a surface protein

#82
20160368950
2016-12-22

Immunogenic compositions and methods

#83
20160346373
2016-12-01

Algal based edible vaccines

#84
20160333426
2016-11-17

Alternative splicing variant of OATP1B3 mRNA

#85
20160324960
2016-11-10

Adjuvant for mucosal vaccine

#86
20160215058
2016-07-28

Single-chain variable fragment anti-CD133 antibodies and uses thereof

#87
20160188790
2016-06-30

Rotavirus particles with chimeric surface proteins

#88
20160160205
2016-06-09

Parkin ligase activation methods and compositions

#89
20160137720
2016-05-19

Method for refining protein including self-cutting cassette and use thereof

#90
20160137707
2016-05-19

SYNAPTOGENIC PROTEIN TAGGED WITH BIOTIN AND RECONSTITUTION OF ARTIFICIAL SYNAPSE BY USING SAME

#91
20160115245
2016-04-28

Single domain antibodies against SOD1 and their use in medicine

#92
20160102130
2016-04-14

Water soluble G-protein coupled receptor

#93
20160038584
2016-02-11

Vaccines for human papilloma virus and methods for using the same

#94
20160022806
2016-01-28

Influenza nucleic acid molecules and vaccines made therefrom

#95
20150307866
2015-10-29

Asparaginase and treating diseases associated with asparagine dependence

#96
20150225467
2015-08-13

NOVEL FAR RED FLUORESCENT PROTEIN

#97
20150141616
2015-05-21

Disulfide stabilized foldon polypeptides

#98
20150140641
2015-05-21

Endoglucanase variants

#99
20150132331
2015-05-14

Influenza vaccine constructs

#100
20150125483
2015-05-07

Fusion proteins of ciliate granule lattice proteins, granular protein particles thereof, and uses therefor

#101
20150118184
2015-04-30

Anti-LAMP5 antibody and utilization thereof

#102
20150105286
2015-04-16

BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology

#103
20150099708
2015-04-09

Wnt compositions and therapeutic uses of such compositions

#104
20150080288
2015-03-19

Nitration shielding peptides and methods of use thereof

#105
20150051158
2015-02-19

CTLA4 proteins and their uses

#106
20150040254
2015-02-05

Porcine CD28 receptor, gene for encoding same, and application of same

#107
20150037349
2015-02-05

Anti-tumor necrosis factor-alpha agents and uses thereof

#108
20150031107
2015-01-29

PCR reaction mixtures with decreased non-specific activity

#109
20150024038
2015-01-22

Immunogenic compositions and methods

#110
20150018665
2015-01-15

MOLECULAR AND CELLULAR IMAGING USING ENGINEERED HEMODYNAMIC RESPONSES

#111
20150011417
2015-01-08

Membrane span-kinase fusion protein and the uses thereof

#112
20140302095
2014-10-09

porins and toxins and related methods

#113
20140248682
2014-09-04

HSA-related compositions and methods of use

#114
20140248255
2014-09-04

Asparaginase and treating diseases associated with asparagine dependence

#115
20140142046
2014-05-22

Wnt compositions and therapeutic uses of such compositions

#116
20140127806
2014-05-08

Modified laminin and use thereof

#117
20140017792
2014-01-16

Vector particles for targeting CD34+ cells

#118
20130330338
2013-12-12

CTLA4 proteins and their uses

#119
20130323752
2013-12-05

BLID; a novel protein domain for interaction with the Bcl-2 family of proteins

#120
20130280173
2013-10-24

Reporter genes for magnetic resonance imaging and methods of use thereof

#121
20130224202
2013-08-29

Single chain variable fragment anti-CD133 antibodies and uses thereof

#122
20130210004
2013-08-15

EGFR-related polypeptides and methods of use

#123
20130203101
2013-08-08

Method and system for purifying and quantitating proteins using heme fusion tags

#124
20130203064
2013-08-08

Alternative splicing variant of OATP1B3 mRNA

#125
20130195909
2013-08-01

Composite antigenic sequences and vaccines

#126
20130171140
2013-07-04

Homodimeric protein constructs

#127
20130164820
2013-06-27

Protease screening methods and proteases identified thereby

#128
20130084291
2013-04-04

Compositions and methods for increasing serum half-life

#129
20130053322
2013-02-28

HSA-related compositions and methods of use

#130
20130052193
2013-02-28

Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)

#131
20130014288
2013-01-10

NOVEL REPORTER-TAGGED RECOMBINANT MEMBRANE PROTEINS WITH TRANSMEMBRANE LINKERS

#132
20120308551
2012-12-06

Protease screening methods and proteases identified thereby

#133
20120301945
2012-11-29

PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY

#134
20120283184
2012-11-08

Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides

#135
20120258500
2012-10-11

PCR reaction mixtures with decreased non-specific activity

#136
20120231474
2012-09-13

CONSTRUCTS THAT ALLOW FOR DETECTION AND QUANTITATION OF MEMBRANE PROTEINS

#137
20120208235
2012-08-16

Endoglucanase variants

#138
20120141983
2012-06-07

Quantitative Aggregation Sensors

#139
20120014977
2012-01-19

Alternative splicing variant of OATP1B3 mRNA

#140
20120003222
2012-01-05

FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same

#141
20110305712
2011-12-15

CTLA4 proteins and their uses

#142
20110244447
2011-10-06

Cognate sampling kinetics

#143
20110201560
2011-08-18

Peptides for inhibiting the HPV-E6 oncoprotein

#144
20110129490
2011-06-02

MODULATION OF PRODUCTION OF RETROVIRUSES BY APOBEC4

#145
20110040079
2011-02-17

Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

#146
20110003385
2011-01-06

REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS

#147
20100323420
2010-12-23

Regulated apoptosis

#148
20100322956
2010-12-23

METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S

#149
20100310549
2010-12-09

Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors

#150
20100247497
2010-09-30

Vector particles for targeting CD34+ cells

#151
20100215694
2010-08-26

Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

#152
20100029912
2010-02-04

Fusion protein

#153
20090298955
2009-12-03

ALTERED VIRUS CAPSID PROTEIN AND USE THEREOF

#154
20090130691
2009-05-21

SCREENING PROTEINASE MODULATORS USING A CHIMERIC PROTEIN AND SKI-I PROPROTEIN CONVERTASE SUBSTRATES AND INHIBITORS

#155
20090130084
2009-05-21

Tagged IgA1 proteases

#156
20090123452
2009-05-14

Protease screening methods and proteases identified thereby

#157
20090081202
2009-03-26

Immunogenic compositions and methods

#158
20090060888
2009-03-05

Regulated transcription of targeted genes and other biological events

#159
20090041746
2009-02-12

Combination therapy with IgA1 proteases

#160
20080254061
2008-10-16

Mycobacteria expressing HIV-1 and malaria antigens

#161
20070298973
2007-12-27

Methods and compositions comprising GFP

#162
20070218026
2007-09-20

DNA encoding the human serine protease EOS

#163
20070209082
2007-09-06

Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby

#164
20070160533
2007-07-12

Pharmacokinetic modulation and compositions for modified FN3 polypeptides

#165
20070148126
2007-06-28

Inhibitors of type 2 vascular endothelial growth factor receptors

#166
20070116720
2007-05-24

Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

#167
20070071724
2007-03-29

Peptide having hydrolase activity

#168
20060223055
2006-10-05

Methods and compositions for treatment of viral lnfection

#169
20060210536
2006-09-21

Methods and compositions for inhibiting stat signaling pathways

#170
20060188508
2006-08-24

Methods and compositions for modulating angiogenesis

#171
20060160761
2006-07-20

Regulation of vascular endothelium using BMX tyrosine kinase

#172
20060078969
2006-04-13

Regulated transcription of targeted genes and other biological events

#173
20060035325
2006-02-16

Regulated apoptosis

#174
20050233422
2005-10-20

Rapid and enzymeless cloning of nucleic acid fragments

#175
20050136062
2005-06-23

Treatment of IgA1 deposition diseases

#176
20050084885
2005-04-21

Zinc finger protein derivatives and methods therefor

#177
20050019752
2005-01-27

Novel chimeric rev, tat, and nef antigens

#178
20050014242
2005-01-20

Zymogen activation system